Kaitlyn Dunn is of counsel in the firm’s Chicago office. She focuses her practice on health care fraud and abuse, regulatory compliance, government investigations, and strategic transactional matters. Katie works with a diverse array of clients, including hospitals and health systems; physician practices; post-acute care providers; ancillary service providers; private equity investors; and pharmaceutical, medical device, and other life sciences companies.
Katie assists clients in navigating the complex health care regulatory environment, including with respect to Medicare and Medicaid billing and reimbursement-related issues; licensure and payer enrollment requirements; and development and implementation of arrangements to comply with the Anti-Kickback Statute (AKS), Stark Law, and other fraud and abuse authorities. Katie also provides regulatory support in connection with health care mergers, acquisitions, private equity transactions, and joint venture arrangements. Finally, Katie aids health care providers and life sciences companies in efficiently and effectively responding to civil, criminal, and administrative enforcement actions, including False Claims Act (FCA) matters, Civil Monetary Penalties Law investigations, and third-party payer audits.
Prior to entering private practice, Katie served as an associate counsel with the Office of Inspector General for the U.S. Department of Health & Human Services (OIG). In that capacity, Katie functioned as Team Leader for the New York, Chicago, and Kansas City regions, and worked closely with the Department of Justice to litigate and resolve dozens of FCA cases involving alleged violations of the AKS, Stark Law, and Medicare and Medicaid payment rules. While with OIG, Katie was instrumental in the negotiation of multiple novel Corporate Integrity Agreements and assisted in the formulation of new guidance on the OIG’s exercise of its permissive exclusion authorities. Katie received an Inspector General’s Award for Excellence in Fighting Fraud, Waste, and Abuse during her tenure with OIG.